Thu, 25th Feb 2021 16:30
BRUSSELS, Feb 25 (Reuters) - AstraZeneca's Chief Executive
Pascal Soriot said on Thursday he hoped to meet the European
Union's expectations on the number of COVID-19 vaccines the
company can deliver to the bloc in the second quarter of the
year.
"We are working 24/7 to improve delivery and hopefully catch
up to the expectations for Q2," he told EU lawmakers in a public
hearing.
(Reporting by Francesco Guarascio @fraguarascio
Editing by Susan Fenton)
(Alliance News) - AstraZeneca PLC on Wednesday said its Farxiga treatment has been approved in the US to treat some diabetes sufferers.
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:
(Alliance News) - AstraZeneca PLC on Monday celebrated a breakthrough therapy designation for its cancer drug Tagrisso, aimed at treating a form of no...
(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's lat...
(Sharecast News) - Stocks in London look primed for a lower start as investors digest the gains made by far right parties in Austria, Germany, but abo...
Astrazeneca (AZN)